PD-L1 expression has been shown to have an impact on prognosis in breast cancer and Merkel cell carcinoma patients, but the prognostic implications of PD-L1 expression are controversial for patients with lung cancer, colon cancer, and melanoma (84). This evidence concerns the gene CD274 and Merkel cell skin cancer.